计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| M413996-1mg |
1mg |
现货 ![]() |
| |
| M413996-5mg |
5mg |
期货 ![]() |
| |
| M413996-10mg |
10mg |
现货 ![]() |
| |
| M413996-25mg |
25mg |
期货 ![]() |
| |
| M413996-50mg |
50mg |
现货 ![]() |
| |
| M413996-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | Methanone |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | MSC2530818 |
| 生化机理 | MSC2530818 是一种 IC50 值为 2.6 nM 的 CDK8 抑制剂,具有出色的激酶选择性、生化和细胞效力、微粒体稳定性和口服生物利用度。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
Information MSC2530818 MSC2530818, a CDK8 inhibitor with the IC50 of 2.6 nM, displays excellent kinase selectivity, biochemical and cellular potency, microsomal stability, and is orally bioavailable. Targets CDK8 (Cell-free assay) 2.6 nM In vitro MSC2530818 binds to CDK8 and CDK19 with similar affinity (4 nM) and shows potent inhibition of phospho-STAT1SER727 in SW620 human colorectal carcinoma cells (IC50=8 ± 2 nM). It also demonstrates potent inhibition of WNT-dependent transcription in human cancer cell lines that have constitutively activated WNT signaling. MSC2530818 is a soluble CDK8 inhibitor with high permeability and low efflux ratio in Caco-2 cells (ER = 1.5) and does not inhibit any cytochrome P450 subtypes (Cyp IC50s > 20 μM). In vivo MSC2530818 shows acceptable pharmacokinetics (PK) in all tested preclinical species (mouse, rat, dog). It demonstrates reduction of tumor growth rates of established human SW620 colorectal carcinoma xenografts. |
| 纯度 | ≥98% |
| ALogP | 2.956 |
|---|---|
| hba_count | 3 |
| HBD Count | 1 |
| Rotatable Bond | 2 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504772894 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | [(2S)-2-(4-chlorophenyl)pyrrolidin-1-yl]-(3-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl)methanone |
| INCHI | 1S/C18H17ClN4O/c1-11-15-9-13(10-20-17(15)22-21-11)18(24)23-8-2-3-16(23)12-4-6-14(19)7-5-12/h4-7,9-10,16H,2-3,8H2,1H3,(H,20,21,22)/t16-/m0/s1 |
| InChi Key | ODRITQGYYWHQGM-INIZCTEOSA-N |
| Smiles | CC1=C2C=C(C=NC2=NN1)C(=O)N3CCCC3C4=CC=C(C=C4)Cl |
| Isomeric SMILES | CC1=C2C=C(C=NC2=NN1)C(=O)N3CCC[C@H]3C4=CC=C(C=C4)Cl |
| 分子量 | 340.81 |
| Reaxy-Rn | 56084385 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=56084385&ln= |
| 溶解性 | Solubility (25°C) In vitro DMSO: 68 mg/mL (199.52 mM); Ethanol: 68 mg/mL (199.52 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 68 |
| DMSO(mM) Max Solubility | 199.5246618 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 340.800 g/mol |
| XLogP3 | 3.300 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 340.109 Da |
| 单同位素质量Monoisotopic Mass | 340.109 Da |
| 拓扑极表面积Topological Polar Surface Area | 61.900 Ų |
| 重原子数Heavy Atom Count | 24 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 468.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P301+P312: 如误吞咽:如感觉不适,呼叫急救中心/医生。 P302+P352: 如皮肤沾染:用水充分清洗。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 |